Moehler, M. Et Al. 2021. Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100. JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.9 .

Moehler, M., Dvorkin, M., Boku, N., ÖZGÜROĞLU, M., Ryu, M., Muntean, A. S., ... Lonardi, S.(2021). Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100. JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.9.

Moehler, Markus Et Al. "Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100," JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.9, 2021

Moehler, Markus Et Al. "Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100." JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.9, 2021

Moehler, M. Et Al. (2021) . "Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100." JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.9.

@article{article, author={Markus Moehler Et Al. }, title={Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2021}